Form 4: Molina Healthcare Director Daniel Cooperman Acquires Shares Under Equity Incentive Plan

Director Daniel Cooperman acquired 189 shares of Molina Healthcare stock as part of the company's 2019 Equity Incentive Plan.

Summary

• Daniel Cooperman, a director at Molina Healthcare, acquired 189 shares of common stock on January 1, 2025.
• The shares were granted under the company's 2019 Equity Incentive Plan as part of his compensation for serving as a director.
• The grant was valued at $55,000, which is one quarter of the annual equity award for directors.
• The number of shares was calculated based on the closing price of Molina Healthcare's stock on December 31, 2024, which was $291.05 per share.
• The total number of shares beneficially owned by Mr. Cooperman after this transaction is 6,327.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns interests. There are no indications of any negative sentiment.

Positives

• The equity grant aligns director compensation with company performance.
• The grant demonstrates continued director engagement and investment in the company.

Industry Context

This is a standard practice for director compensation in publicly traded companies, aligning their interests with shareholders through equity ownership.

Comparison to Industry Standards

• Equity grants are a common form of compensation for directors in publicly traded companies like Molina Healthcare.
• Companies such as UnitedHealth Group (UNH) and Humana (HUM) also use similar equity-based compensation plans for their directors.
• The value of the grant is consistent with typical director compensation packages in the healthcare industry.

Stakeholder Impact

• The stock grant increases director alignment with shareholder interests.
• The grant does not have a material impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Molina Healthcare, Director, Equity Incentive Plan, Stock Grant, Beneficial Ownership, Form 4, Daniel Cooperman